OpenScience.ink

1 week ago • Journal of International Society of Preventive & Community Dentistry

📖 Top 50% JournalArticle

1 week ago • Frontiers in public health

Cost-effectiveness of loxenatide compared to DPP-4 inhibitors for Chinese people with type 2 diabetes and high heart disease riskCost-utility analysis of loxenatide versus DPP-4 inhibitors in Chinese patients with type 2 diabetes at high cardiovascular risk.

📖 Top 20% JournalFulltext (Open License)Comparative Study

1 week ago • Cureus

GLP-1 and GIP/GLP-1 Receptor Drugs for Weight Gain Caused by Antipsychotic Medicines: A ReviewGLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide)/GLP-1 Receptor Agonists for Antipsychotic-Induced Weight Gain: A Narrative Review.

Article

1 week ago • Frontiers in pharmacology

Oral small-molecule drugs that activate GLP-1 receptors: a new approach in heart and metabolism healthOral small-molecule GLP-1 receptor agonists: a new Frontier in cardiometabolic medicine.

📖 Top 20% JournalFulltext (Open License)Article

1 week ago • Frontiers in endocrinology

Tirzepatide may improve blood sugar control in Rabson-Mendenhall syndromeCase Report: Tirzepatide improves glycemic control in Rabson-Mendenhall syndrome.

🎖️ Top 10% JournalFulltext (Open License)Case Reports

1 week ago • Cureus

Diabetes, Body Fat, and Physical Function in Heart Failure with Preserved Pumping: A Review of Recent Treatment ResponsesDiabetes, Adiposity, and Functional Phenotypes in HFpEF: A Systematic Review of Recent Treatment-Response Evidence.

Article

1 week ago • Dermatology and therapy

Increasing use of GLP-1 and combined GIP/GLP-1 drugs in skin health and treatment, from immune and metabolism effects to patient careThe Expanding Role of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Agonists in Dermatology: From Immunometabolism to Clinical Practice.

🎖️ Top 10% JournalArticle

1 week ago • Antioxidants & redox signaling

SGK2 helps reduce diabetic kidney damage by blocking cell death through NEDD4L-driven ACSL4 breakdownSGK2 Promotes NEDD4L-Mediated ACSL4 Ubiquitination to Inhibit Ferroptosis and Alleviate Diabetic Kidney Disease.

🥉 Top 5% JournalArticle

1 week ago • Drugs

Effects of GLP-1 Receptor Agonists on Muscle and Bone Health: A Review and AnalysisGLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.

🥈 Top 2% JournalSystematic Review

1 week ago • Journal of asthma and allergy

Risk of Asthma Attacks with Tirzepatide Compared to Semaglutide in People with Asthma and Type 2 DiabetesAssociation of Tirzepatide versus Semaglutide with Risk of Asthma Exacerbation in Patients with Asthma and Type 2 Diabetes: A US Multicenter Retrospective Cohort Study.

📖 Top 20% JournalArticle

1 week ago • PeerJ

Weight gain after stopping diabetes-related hormone treatments in overweight or obese adults: a review and analysisWeight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysis.

📖 Top 30% JournalFulltext (Open License)Systematic Review

1 week ago • The Knee

Recovery after knee replacement in type 2 diabetes patients treated with semaglutide versus tirzepatidePostoperative outcomes after total knee arthroplasty in type 2 diabetes mellitus patients receiving semaglutide versus tirzepatide: a propensity score-matched national research network analysis.

📖 Top 30% JournalArticle

1 week ago • Biomedical journal

Structural Details of GLP-1 Drug VersionsStructural Overview of GLP-1 Analogs.

📖 Top 20% JournalArticle

1 week ago • Frontiers in endocrinology

GLP-1 drugs and the risk of kidney injury after heart procedures in people with Type 2 diabetesEffects of GLP-1 receptor agonists on the incidence of contrast-induced acute kidney injury in patients with Type 2 diabetes mellitus undergoing coronary interventions.

🎖️ Top 10% JournalArticle

1 week ago • Frontiers in pharmacology

Reports of suicide and self-injury linked to liraglutide, semaglutide, and tirzepatide from European drug safety dataReporting patterns of suicide- and self-injury-related events involving liraglutide, semaglutide, and tirzepatide: data from the European pharmacovigilance database.

📖 Top 20% JournalArticle

1 week ago • F1000Research

Liraglutide's effects on weight and reproductive health in women with obesity and PCOSRole of Liraglutide in weight management and reproductive health in women with obesity and PCOS- A critical review of the evidence.

📖 Top 50% JournalArticle

1 week ago • Frontiers in cardiovascular medicine

Glucagon-like peptide-1 receptor drugs linked to return of irregular heartbeat after heart rhythm treatmentAssociation of glucagon-like peptide-1 receptor agonists with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis.

📖 Top 20% JournalSystematic Review

1 week ago • Cureus

Brain and mental effects of diabetes drugs acting on GLP-1 receptors in schizophrenia-related disorders: A systematic reviewNeuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review.

Article

1 week ago • Clinical and experimental hepatology

New treatments for long-term liver diseases focusing on fat-related liver scarringRecent advances in the treatment of chronic liver diseases: focus on MASLD/MASH-related fibrosis.

📖 Top 50% JournalArticle

1 week ago • Frontiers in endocrinology

Saudi doctors' knowledge, views, and use of diabetes medicines SGLT-2 inhibitors and GLP-1 receptor agonistsKnowledge, attitudes, and practices of Saudi physicians toward the use of SGLT-2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus: a nationwide cross-sectional study.

🎖️ Top 10% JournalArticle

1 week ago • Frontiers in endocrinology

Lower starting blood sugar and kidney function link to less favorable body changes after SGLT2 inhibitor treatment in type 2 diabetesLow baseline HbA1c and reduced eGFR are associated with relatively unfavorable body recomposition after SGLT2 inhibitor therapy in type 2 diabetes.

🎖️ Top 10% JournalMulticenter Study

1 week ago • Diabetes, obesity & metabolism

Effectiveness and Safety of Glucagon-Like Peptide-1 Medicines Added to Insulin for Type 1 DiabetesEfficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists as Adjuncts to Insulin Therapy in Type 1 Diabetes Mellitus: An Overlap-Informed Umbrella Review.

Article

1 week ago • Clinics in dermatology

GLP-1 Receptor Agonists as Possible Treatments for Skin Conditions Linked to Other DiseasesWhere the Future Lies: GLP-1 Receptor Agonists as Therapeutics for Dermatologic Comorbidities.

📖 Top 50% JournalArticle

1 week ago • Clinical journal of the American Society of Nephrology : CJASN

Obesity and Heart-Related Health in Kidney Disease: Effects on Kidney Function, Risk Levels, and TreatmentObesity and Cardio-Metabolic Health in Kidney Disease: Implications for Kidney Health, Risk Stratification, and Management.

🥉 Top 5% JournalArticle

1 week ago • Hip international : the journal of clinical and experimental research on hip pathology and therapy

Use of GLP-1 receptor drugs before hip replacement and surgery outcomesPreoperative GLP-1 receptor agonist use and outcomes after total hip arthroplasty: a matched cohort study.

📖 Top 30% JournalArticle

1 week ago • Journal of eating disorders

Fasting gut hormone levels after long-term recovery from Anorexia NervosaFasting gut hormone levels following long-term recovery from Anorexia Nervosa: A cross-sectional study.

📖 Top 20% JournalArticle

1 week ago • Gut

Expert review on using resmetirom and semaglutide to treat liver scarring from fatty liver diseaseInternational expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update.

🥇 Top 1% JournalArticle

1 week ago • Molecular and cellular endocrinology

Metabolic effects of a diabetes drug combined with aerobic exercise in rats without ovariesMetabolic Effects of a GLP-1 Analog Combined with Aerobic Training in Ovariectomized Rats.

📖 Top 20% JournalArticle

1 week ago • Cureus

Heart and Kidney Benefits in Type 2 Diabetes Compared Between Two Diabetes Drug TypesCardiorenal Protection in Type 2 Diabetes: A Systematic Review Comparing Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors.

Article

1 week ago • Hormones (Athens, Greece)

Improvement in small nerve damage seen in the eye after semaglutide treatment: a case report and reviewImprovement of small fiber neuropathy assessed by corneal confocal microscopy following semaglutide treatment: a case report and literature review.

📖 Top 30% JournalArticle

← prevpage 4 of 14next →

Latest GLP-1 Therapies Research Papers